EPO and depressive disorder: In a randomized, double-blind, placebo-controlled study of treatment-resistant depression, EPO did not improve Hamilton Depression Rating Scale-17 (HDRS-17) scores after an 8-weeks dosing regimen (Miskowiak et al., 2014b).